Scientists

Elon Musk, Brian Eno, and Apollo 11 Documentary Will Be Honored by STARMUS with the 2019 Stephen Hawking Medal for Science Communication

Retrieved on: 
Friday, May 10, 2019
Entertainment, Music, Technology, Hardware, Software, Transport, Satellite, Security, Other Transport, Travel, Transportation, Film & Motion Pictures, Research, Other Science, Science, Physical sciences, Science, Scientists, Starmus Festival, Cosmologists, Stephen Hawking, Stephen Hawking Medal for Science Communication, Neil deGrasse Tyson, Hawking, CQS, Michael Hintze

The STARMUS festival announces the 2019 winners of the Stephen Hawking Medal, one of the worlds most celebrated science communication awards.

Key Points: 
  • The STARMUS festival announces the 2019 winners of the Stephen Hawking Medal, one of the worlds most celebrated science communication awards.
  • It will be a momentous occasion, with Mr. May and Mr. Musk flanked by the Apollo astronauts in a not-to-miss photo opportunity.
  • Sir Michael Hintze, Founder and Group Executive Chairman of CQS added, I am excited about our support for Starmus and the 2019 Stephen Hawking Medal.
  • Previous recipients of the Stephen Hawking Medal include Mr. Zimmer, Neil deGrasse Tyson, Jean-Michel Jarre, and The Big Bang Theory.

Frank Mitloehner Honored With Science Communication Award

Retrieved on: 
Tuesday, April 16, 2019
Awards, National academies, Scientists, American Council on Science and Health, Mexican Academy of Sciences, Norman Borlaug, Rockefeller Foundation, University of Minnesota, Borlaug CAST Communication Award, IOWA, Alison Van Eenennaam

AMES, Iowa, April 16, 2019 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology named Dr. Frank Mitloehner the 2019 Borlaug CAST Communication Award recipient.

Key Points: 
  • AMES, Iowa, April 16, 2019 /PRNewswire-PRWeb/ -- The Council for Agricultural Science and Technology named Dr. Frank Mitloehner the 2019 Borlaug CAST Communication Award recipient.
  • Mitloehner, a professor and air quality extension specialist in the Department of Animal Science at the University of California-Davis, is the 10th recipient of this award.
  • "Being recognized with the Borlaug CAST Communication Award is not only a high honor, it's an affirmation of the importance of sharing research and academic pursuits well beyond labs, classrooms, and universities."
  • The nominee must show remarkable communication skills through various types of media with the purpose of advancing science in the public policy sector.

Both Nobel Prize Winner and World-Leading Clinician Join Dragonfly Therapeutics' Scientific Leadership Team

Retrieved on: 
Wednesday, April 10, 2019
Awards, Science, Harold E. Varmus, Nobel Prize in Physiology or Medicine, Nobel Prize, Scientists

WALTHAM, Mass., April 10, 2019 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly"), today announced the addition of two internationally-recognized researchers to its scientific leadership team.

Key Points: 
  • WALTHAM, Mass., April 10, 2019 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly"), today announced the addition of two internationally-recognized researchers to its scientific leadership team.
  • Nobel Prize winner Dr. James ("Jim") Allison, Ph.D., joins Dragonfly's Scientific Advisory Board.
  • Dr. Allison joins Nobel Prize winner Harold Varmus, M.D., and an outstanding group of clinicians and scientists on Dragonfly's Scientific Advisory Board.
  • Dr. Allison, was awarded the Nobel Prize in Physiology or Medicine in 2018 for his groundbreaking work in cancer immunotherapy.

Euroepan Point-of-Care, Biosensors & Mobile Diagnostics Conference 2019 - Rotterdam, Netherlands - June 18th-19th, 2019

Retrieved on: 
Tuesday, February 19, 2019
Sabeth Verpoorte, Nancy Allbritton, Women, Scientists, Science and technology

Elisabeth Verpoorte, Professor of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen, Netherlands

Key Points: 
  • Elisabeth Verpoorte, Professor of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen, Netherlands
    Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology, United States of America
    Nancy Allbritton, Kenan Professor of Chemistry and Biomedical Engineering and Chair of the Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, United States of America
    Martyn Boutelle, Professor of Biomedical Sensors Engineering, Vice Chair Department of Bioengineering, Imperial College London, United Kingdom
    I'll be presenting a novel and disruptive detection technology for Point of Care diagnostics.
  • The presentation includes the underlying physics, implementation solutions and testing data of this unique technology platform.
  • Patrick Wagner, Professor, Soft-Matter Physics and Biophysics Section, Departement Natuurkunde en Sterrenkunde, Katholieke Universiteit Leuven, Belgium
    Jean-Manuel Segura, Professor, University of Applied Sciences and Arts Western Switzerland Valais, Switzerland
    Arben Merkoi, ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Catal de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST), Spain
    Session Title: Technologies in Biosensors and Point-of-Care, Point-of-Need Diagnostics
    Jonathan Cooper, Wolfson Professor and University Vice Principal, Glasgow University, United Kingdom
    Rapid Diagnosis of Breast Cancer: Innovative Approaches with a Focus on Low Resource Setting
    Barbara Smith, Assistant Professor, School of Biological and Health Systems Engineering, Arizona State University, United States of America

Hummingbird Bioscience Announces Nobel Laureate Dr. James Allison and Dr. Padmanee Sharma Join its Scientific Advisory Board

Retrieved on: 
Monday, February 18, 2019
Fellows of the American Association for the Advancement of Science, James P. Allison, Scientists, Science and technology in the United States, Medicine

SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- Hummingbird Bioscience , a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.

Key Points: 
  • SINGAPORE, Feb. 18, 2019 /PRNewswire/ -- Hummingbird Bioscience , a systems-biology enabled biotech company focused on the discovery and development of novel cancer therapeutics, today announced James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D., have joined its Scientific Advisory Board.
  • "I am pleased to join the Scientific Advisory Board of Hummingbird Bioscience at this exciting moment in the development of its pipeline ," said Dr. Allison.
  • "It is wonderful opportunity to be a part of the Hummingbird Bioscience Scientific Advisory Board," said Dr. Sharma.
  • Allison and Sharma join our board of scientific advisors," said Piers Ingram , Ph.D., CEO of Hummingbird Bioscience.

L'Oréal And UNESCO Award U.S.-Based Physicist And Applied Mathematician For Outstanding Scientific Achievements

Retrieved on: 
Monday, February 11, 2019
Ingrid Daubechies, Simons Investigator, Scientists, Duke University, Learned societies, American culture

Professor Daubechies will be awarded with 100,000 for her exceptional research in Mathematics and honored at an awards ceremony in Paris on March 14, 2019.

Key Points: 
  • Professor Daubechies will be awarded with 100,000 for her exceptional research in Mathematics and honored at an awards ceremony in Paris on March 14, 2019.
  • Professor Daubechies is an accomplished physicist and applied mathematician; she currently holds the title of Professor of Mathematics at Duke University.
  • "L'Oral is proud to honor Professor Daubechies for her outstanding achievements and ground-breaking work in mathematics," said Lauren Paige, Vice President of Public Affairs and Strategic Initiatives at L'Oral USA.
  • Since 1998, the L'Oral Foundation, in partnership with UNESCO, has worked to improve the representation of women in scientific careers.

EPAM Leads Investment in $50 Million Regional GO Philly Fund, a Blockchain-Enabled Venture Fund Operated by Ben Franklin Technology Partners

Retrieved on: 
Thursday, February 7, 2019
Cities in the United States, Writers, Scientists, EPAM Systems, Benjamin Franklin, Philadelphia, Franklin

Under the agreement, EPAM will anchor the initial $15 million close, as well as join the GO Philly Fund's Limited Partner Advisory Committee.

Key Points: 
  • Under the agreement, EPAM will anchor the initial $15 million close, as well as join the GO Philly Fund's Limited Partner Advisory Committee.
  • "We are proud to have EPAM as our lead investor in the GO Philly Fund," said RoseAnn B. Rosenthal, President and CEO of Ben Franklin.
  • Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin) is the most active early stage capital provider for the region's technology sectors.
  • Ben Franklin is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.

EPAM Leads Investment in $50 Million Regional GO Philly Fund, a Blockchain-Enabled Venture Fund Operated by Ben Franklin Technology Partners

Retrieved on: 
Thursday, February 7, 2019
Cities in the United States, Writers, Scientists, EPAM Systems, Benjamin Franklin, Philadelphia, Franklin

Under the agreement, EPAM will anchor the initial $15 million close, as well as join the GO Philly Fund's Limited Partner Advisory Committee.

Key Points: 
  • Under the agreement, EPAM will anchor the initial $15 million close, as well as join the GO Philly Fund's Limited Partner Advisory Committee.
  • "We are proud to have EPAM as our lead investor in the GO Philly Fund," said RoseAnn B. Rosenthal, President and CEO of Ben Franklin.
  • Ben Franklin Technology Partners of Southeastern Pennsylvania (Ben Franklin) is the most active early stage capital provider for the region's technology sectors.
  • Ben Franklin is an initiative of the Pennsylvania Department of Community and Economic Development and is funded by the Ben Franklin Technology Development Authority.

Lyndra Therapeutics Raises $55 Million in Series B Financing

Retrieved on: 
Tuesday, January 29, 2019
Health, Biotechnology, Clinical trials, Mental health, Pharmaceutical, Professional services, Finance, Research, Science, Lemelson–MIT Prize, Robert S. Langer, Scientists, Learned societies, Engineering

Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, expansion of its Phase I pipeline and manufacturing scale-up.

Key Points: 
  • Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced it has raised $55 million in Series B financing, funds it will use for Phase II clinical trials, expansion of its Phase I pipeline and manufacturing scale-up.
  • The diversity and caliber of our investors, including those who joined this round, speaks to the importance of addressing unmet therapeutic need, said Amy Schulman, CEO and co-founder of Lyndra Therapeutics.
  • Lyndras long-acting therapies have the potential to address a diversity of disease states, said Robert Langer, co-founder and Board Member of Lyndra Therapeutics.
  • Lyndra Therapeutics aims to improve healthcare outcomes through oral, ultra-long-acting, sustained-release therapies that change how people take medicines.